Effect of probucol on vascular remodeling due to atherosclerosis in rabbits: an intravascular ultrasound study

被引:7
作者
Li Ting-ting [1 ]
Xie Yi [3 ]
Guo Yuan [1 ]
Tian Hong-bo [4 ]
Zhang Jian-ning [2 ]
Peng Jie [1 ]
Zhang Yun [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan 250012, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Dept Intens Care Unit, Jinan 250012, Shandong, Peoples R China
[3] Shandong Chest Hosp, Dept Resp Med, Jinan 250013, Shandong, Peoples R China
[4] Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan 250021, Shandong, Peoples R China
关键词
arteriosclerosis; intravascular ultrasonography; plaque; vascular remodeling; probucol; DEFICIENT MICE; CELLULAR COMPOSITION; ARTERIAL; HYPERCHOLESTEROLEMIA; PROGRESSION; ANTIOXIDANT; RESTENOSIS; APOPTOSIS; PROLIFERATION; MACROPHAGES;
D O I
10.3760/cma.j.issn.0366-6999.2011.12.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Probucol is known to reduce the development of atherosclerotic lesions, but its impact on vascular remodeling associated with de novo atherosclerosis is incompletely understood. We therefore examined the effect of probucol on vascular remodeling in a rabbit model of established atherosclerosis. Methods Aortic atherosclerosis was induced by a combination of endothelial injury and 10 weeks' atherogenic diet. Animals were then randomized to receive the foregoing diet without or with 1% (wt/wt) probucol for 16 weeks. At the end of week 26, in vivo intravascular ultrasound, pathological, immunohistochemical and gene expression studies were performed. Results Probucol significantly decreased vessel cross-sectional area, plaque area and plaque burden without effect on lumen area. More negative remodeling and less positive remodeling occurred in the abdominal aortas of probucol group than the control group (56% vs. 21%, 18% vs. 54%, respectively, both P<0.01). In addition, the probucol group showed a smaller mean remodeling index relative to the control group (0.93 +/- 0.13 vs. 1.05 +/- 0.16, P <0.01). Furthermore, probucol treatment decreased macrophage infiltration, inhibited apoptosis of cells within plaques, and reduced the production of matrix metalloproteinases-2, -9, cathepsin K and cathepsin S (all P <0.01). Conclusions These findings suggest that probucol may attenuate the enlargement of atherosclerotic vessel walls and be associated with a negative remodeling pattern without affecting the lumen size. This effect may involve inhibition of extracellular matrix degradation and prevention of apoptosis in atherosclerotic plaques. Chin Med J 2011;124(12):1840-1847
引用
收藏
页码:1840 / 1847
页数:8
相关论文
共 37 条
  • [31] Long-term treatment with probucol improves endothelial function in patients with coronary artery disease
    Tagawa, T
    Urabe, Y
    Kimura, Y
    Suzuki, S
    Ono, H
    Takeda, K
    [J]. HYPERTENSION RESEARCH, 2004, 27 (05) : 311 - 318
  • [32] Relationship between coronary artery remodeling and plaque vulnerability
    Varnava, AM
    Mills, PG
    Davies, MJ
    [J]. CIRCULATION, 2002, 105 (08) : 939 - 943
  • [33] Vascular cell apoptosis in remodeling, restenosis, and plaque rupture
    Walsh, K
    Smith, RC
    Kim, HS
    [J]. CIRCULATION RESEARCH, 2000, 87 (03) : 184 - 188
  • [34] Probucol [4,4′-[(1-methylethylidene)bis(thio)]bis-[2,6-bis(1,1-dimethylethyl) phenol]] inhibits compensatory remodeling and promotes lumen loss associated with atherosclerosis in apolipoprotein E-deficient mice
    Wu, Ben J.
    Di Girolamo, Nick
    Beck, Konstanze
    Hanratty, Colm G.
    Choy, Katherine
    Hou, Jing Y.
    Ward, Michael R.
    Stocker, Roland
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (02) : 477 - 484
  • [35] Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging
    Wu, BJ
    Kathir, K
    Witting, PK
    Beck, K
    Choy, K
    Li, C
    Croft, KD
    Mori, TA
    Tanous, D
    Adams, MR
    Lau, AK
    Stocker, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (04) : 1117 - 1127
  • [36] Carvedilol, a pharmacological antioxidant, inhibits neointimal matrix metalloproteinase-2 and-9 in experimental atherosclerosis
    Wu, Tao-Cheng
    Chen, Yung-Hsiang
    Leu, Hsin-Bang
    Chen, Yuh-Lien
    Lin, Feng-Yen
    Lin, Shing-Jong
    Chen, Jaw-Wen
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2007, 43 (11) : 1508 - 1522
  • [37] Long-Term Probucol Treatment Prevents Secondary Cardiovascular Events: a Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan
    Yamashita, Shizuya
    Bujo, Hideaki
    Arai, Hidenori
    Harada-Shiba, Mariko
    Matsui, Shigeyuki
    Fukushima, Masanori
    Saito, Yasushi
    Kita, Toru
    Matsuzawa, Yuji
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2008, 15 (06) : 292 - 303